[Docetaxel in combination with cisplatin for first-line treatment of locally advanced or metastatic non-small cell lung cancer: meta-analysis of randomized and controlled clinical trials].

@article{Lerma2004DocetaxelIC,
  title={[Docetaxel in combination with cisplatin for first-line treatment of locally advanced or metastatic non-small cell lung cancer: meta-analysis of randomized and controlled clinical trials].},
  author={Beatriz S{\'a}nchez Lerma and Iv{\'a}n Pe{\~n}uelas S{\'a}nchez and Francisco Guill{\'e}n Grima},
  journal={Medicina clinica},
  year={2004},
  volume={122 8},
  pages={281-7}
}
BACKGROUND AND OBJECTIVE Recent approval of docetaxel in combination with cisplatin (DP) for non-small cell lung cancer (NSCLC) treatment means that an assessment of its effectiveness and toxicity is necessary. The aim of this study was to evaluate docetaxel/cisplatin combination versus other cisplatin-based regimens as the front-line treatment of… CONTINUE READING